
|Articles|June 13, 2008
Daiichi and Ranbaxy to tie the knot
The largest Indian drugmaker is hooking up with a Japanese pharmaceutical firm.
Advertisement
Ranbaxy, the largest drug company in India, has agreed to sell a majority stake of its firm to the Japanese drugmaker Daiichi Sankyo for up to $4.6 billion. The deal will vault Daiichi into the top ranks of generic companies in this country. Industry insiders believe this move makes sense when generic drug sales are growing like topsy in the United States while brand drug sales have slowed.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































